MedPath
HSA Approval

ACCODEX SOLUTION FOR INJECTION 100MG/ML

SIN16994P

ACCODEX SOLUTION FOR INJECTION 100MG/ML

ACCODEX SOLUTION FOR INJECTION 100MG/ML

April 29, 2024

ACCORD HEALTHCARE PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantACCORD HEALTHCARE PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

V03AB35

Manufacturer Information

ACCORD HEALTHCARE PRIVATE LIMITED

Steril-Gene Life Sciences (P) Limited

Active Ingredients

Sugammadex sodium eqv Sugammadex

100 mg/ml

Sugammadex

Documents

Package Inserts

Accodex PI Apr 2024.pdf

Approved: April 29, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACCODEX SOLUTION FOR INJECTION 100MG/ML - HSA Approval | MedPath